Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs

Intern Emerg Med. 2016 Aug;11(5):637-48. doi: 10.1007/s11739-016-1450-6. Epub 2016 Apr 15.

Abstract

Skin and soft tissue infections (SSTIs) are a common cause of hospital admission among elderly patients, and traditionally have been divided into complicated and uncomplicated SSTIs. In 2010, the FDA provided a new classification of these infections, and a new category of disease, named acute bacterial skin and skin structure infections (ABSSSIs), has been proposed as an independent clinical entity. ABSSSIs include three entities: cellulitis and erysipelas, wound infections, and major cutaneous abscesses This paper revises the epidemiology of SSTIs and ABSSSIs with regard to etiologies, diagnostic techniques, and clinical presentation in the hospital settings. Particular attention is owed to frail patients with multiple comorbidities and underlying significant disease states, hospitalized on internal medicine wards or residing in nursing homes, who appear to be at increased risk of infection due to multi-drug resistant pathogens and treatment failures. Management of ABSSSIs and SSTIs, including evaluation of the hemodynamic state, surgical intervention and treatment with appropriate antibiotic therapy are extensively discussed.

Keywords: Acute bacterial skin and skin structure infections; Elderly patients; Internal medicine wards; New drugs.

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / adverse effects
  • Carbapenems / pharmacokinetics
  • Ceftaroline
  • Cephalosporins / adverse effects
  • Cephalosporins / pharmacokinetics
  • Cephalosporins / therapeutic use
  • Daptomycin / pharmacology
  • Daptomycin / therapeutic use
  • Female
  • Fluoroquinolones / adverse effects
  • Fluoroquinolones / pharmacokinetics
  • Glycopeptides / pharmacology
  • Glycopeptides / therapeutic use
  • Hospitalization
  • Humans
  • Iatrogenic Disease
  • Internal Medicine / methods*
  • Internal Medicine / standards
  • Linezolid / pharmacology
  • Linezolid / therapeutic use
  • Lipoglycopeptides
  • Male
  • Minocycline / analogs & derivatives
  • Minocycline / pharmacology
  • Minocycline / therapeutic use
  • Oxazolidinones / pharmacology
  • Oxazolidinones / therapeutic use
  • Skin Diseases, Infectious / drug therapy*
  • Skin Diseases, Infectious / physiopathology
  • Soft Tissue Infections / drug therapy*
  • Soft Tissue Infections / physiopathology
  • Teicoplanin / analogs & derivatives
  • Teicoplanin / pharmacology
  • Teicoplanin / therapeutic use
  • Tigecycline
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Cephalosporins
  • Fluoroquinolones
  • Glycopeptides
  • Lipoglycopeptides
  • Oxazolidinones
  • Teicoplanin
  • Vancomycin
  • Tigecycline
  • dalbavancin
  • Minocycline
  • Linezolid
  • Daptomycin
  • oritavancin